Hormone replacement therapy (HRT) with small doses of an oestrogen (together with a progestogen in women with a uterus) is appropriate for alleviating menopausal symptoms such as vaginal atrophy or vasomotor instability.

2025年2月26日 · Includes growth chart with average weight and height, by gender and age (neonate, child and adult). Cautionary, warning and advisory labels applied to medications …

Estradiol pessaries or vaginal tablets, and Estring® are used for the prophylaxis of recurrent urinary-tract infection in postmenopausal women, but are not licensed for this indication.

Oral estrogens, especially conjugated estrogens, can reduce the effectiveness of testosterone by increasing sex hormone binding globulin levels. Switching women with HSDD from oral to transdermal estrogen can be beneficial as this can increase the proportion of circulating free testosterone without requiring exogenous testosterone.

High-level prescribing trends for Female sex hormones and their modulators (BNF section 6.4.1) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

Hormone replacement therapy (HRT) is available as oral or transdermal preparations, depending on the woman's preferences. Oestrogen-only preparations are given to women without a uterus, and combined oestrogen and progestogen preparations are …

Oestrogens are necessary for the development of female secondary sexual characteristics. If onset of puberty is delayed because of organic pathology, puberty can be induced with ethinylestradiol in increasing doses, guided by breast staging and uterine scans. Cyclical progestogen replacement is added after 12–18 months of oestrogen treatment.

What information and advice should I give a woman diagnosed with menopause? The stages of menopause, common symptoms, and short- and long-term health implications. Treatment options, such as lifestyle measures, non-hormonal treatments, and hormonal drug treatments.

The BNF aims to provide prescribers, pharmacists, and other healthcare professionals with sound up-to-date information about the use of medicines. The BNF includes key information on the selection, prescribing, dispensing and administration of medicines.

Testosterone gel (Testim®/Testogel®/Tostran®) is recommended for restricted use for women in the menopause with Hypoactive Sexual Desire Disorder (HSDD) / Female Androgen Deficiency Syndrome (FADS) if Hormone Replacement Therapy (HRT) alone is …